chr1-214613402-C-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_016343.4(CENPF):c.-41-312C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0062 in 194,732 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0077 ( 16 hom., cov: 32)
Exomes 𝑓: 0.00068 ( 0 hom. )
Consequence
CENPF
NM_016343.4 intron
NM_016343.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.180
Genes affected
CENPF (HGNC:1857): (centromere protein F) This gene encodes a protein that associates with the centromere-kinetochore complex. The protein is a component of the nuclear matrix during the G2 phase of interphase. In late G2 the protein associates with the kinetochore and maintains this association through early anaphase. It localizes to the spindle midzone and the intracellular bridge in late anaphase and telophase, respectively, and is thought to be subsequently degraded. The localization of this protein suggests that it may play a role in chromosome segregation during mitotis. It is thought to form either a homodimer or heterodimer. Autoantibodies against this protein have been found in patients with cancer or graft versus host disease. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 1-214613402-C-A is Benign according to our data. Variant chr1-214613402-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 1198092.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00774 (1178/152132) while in subpopulation AFR AF = 0.0272 (1127/41480). AF 95% confidence interval is 0.0259. There are 16 homozygotes in GnomAd4. There are 554 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 16 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CENPF | NM_016343.4 | c.-41-312C>A | intron_variant | Intron 1 of 19 | ENST00000366955.8 | NP_057427.3 | ||
CENPF | XM_017000086.3 | c.-219C>A | 5_prime_UTR_variant | Exon 1 of 20 | XP_016855575.1 | |||
CENPF | XM_011509082.4 | c.-41-312C>A | intron_variant | Intron 1 of 18 | XP_011507384.1 | |||
UBE2V1P13 | n.214613402C>A | intragenic_variant |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00770 AC: 1171AN: 152014Hom.: 16 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1171
AN:
152014
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000681 AC: 29AN: 42600Hom.: 0 Cov.: 0 AF XY: 0.000957 AC XY: 22AN XY: 22996 show subpopulations
GnomAD4 exome
AF:
AC:
29
AN:
42600
Hom.:
Cov.:
0
AF XY:
AC XY:
22
AN XY:
22996
Gnomad4 AFR exome
AF:
AC:
20
AN:
1322
Gnomad4 AMR exome
AF:
AC:
2
AN:
1470
Gnomad4 ASJ exome
AF:
AC:
0
AN:
1018
Gnomad4 EAS exome
AF:
AC:
0
AN:
1382
Gnomad4 SAS exome
AF:
AC:
0
AN:
5000
Gnomad4 FIN exome
AF:
AC:
0
AN:
3204
Gnomad4 NFE exome
AF:
AC:
3
AN:
26602
Gnomad4 Remaining exome
AF:
AC:
4
AN:
2442
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00774 AC: 1178AN: 152132Hom.: 16 Cov.: 32 AF XY: 0.00745 AC XY: 554AN XY: 74352 show subpopulations
GnomAD4 genome
AF:
AC:
1178
AN:
152132
Hom.:
Cov.:
32
AF XY:
AC XY:
554
AN XY:
74352
Gnomad4 AFR
AF:
AC:
0.0271697
AN:
0.0271697
Gnomad4 AMR
AF:
AC:
0.00248593
AN:
0.00248593
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.0002079
AN:
0.0002079
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.0000735143
AN:
0.0000735143
Gnomad4 OTH
AF:
AC:
0.00284091
AN:
0.00284091
Heterozygous variant carriers
0
58
117
175
234
292
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jul 17, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at